Funding transparency
Support cannot purchase the Promise.
Publish the reviewed institutional relationship and effect. Protect the raw financial and personal source record.
This page reads the repository’s canonical public relationship and opportunity registers at build time. It does not maintain a separate sponsor database, accept support, process money, rank providers, or create charitable, tax, nonprofit, ownership, or public-benefit status.
Canonical relationship register
Material relationships.
Schema 0.1.0, registry revision 1, reviewed 2026-07-26. Information class: PUBLIC.
No accepted funding relationships are recorded.
This registry contains no accepted funding relationships. It is a public institutional register, not a bank ledger, tax ledger, payment system, donor CRM, contract archive, payroll system, or private accounting source.
Registry status: phase-0-baseline. Website rendering cannot accept, amend, refund, terminate, or supersede a relationship.
Canonical opportunity register
Public-good opportunities.
An opportunity is not open merely because a need is documented. It requires an explicit open status and approved recipient, custody, privacy, accounting, refund, and public-record links.
No live funding opportunity is published.
No opportunity in this file is open for payment or sponsorship unless its record explicitly has status open and links to an approved legal recipient, custody route, privacy notice, accounting owner, refund behavior, and public funding record. This baseline currently contains no live opportunity.
Recognition versus influence
Attribution is not authority.
Every material relationship must enumerate exact approved benefits, conflicts, restrictions, dependencies, outcomes, correction paths, and termination behavior in its canonical record.
Permitted after review
- Truthful public acknowledgment of a reviewed relationship, classification, dates, support provided, and canonical funding record.
- Factual attribution on funded public artifacts and outcome reports, including limitations, failures, corrections, suspension, or termination.
- Public briefings available on comparable terms without private product, health, user, or decision access.
- Narrow factual review of names, dates, support amounts or bands, supplied services, restrictions, and rights-cleared marks.
Never for sale
- Personal or private information, health-interest profiling, donor or user lists, or access to protected correspondence and evidence.
- Health recommendations, preferred providers, connector ranking, hidden defaults, clinical placement, or weakened evidence and safety language.
- Guaranteed roadmap priority, release dates, merge authority, issue closure, exclusivity, or veto over correction, rollback, migration, or termination.
- Governance seats, votes, emergency power, reputation, progression, findings, certification, or exemption from conflicts and ordinary review.
Anti-capture review
Dependence is more than a percentage.
Reviews consider financial, in-kind, restriction, critical-function, decision, related-group, and founder-subsidy concentration. The thresholds below trigger review; they do not certify safety.
10% or more
Publish a concentration watch and review restrictions, influence, dependency, and replacement.
20% or more
Require a written diversification, mitigation, replacement, and continuity plan.
33% or more
Presumptively pause additional dependency unless an independently reviewed narrow, time-bounded exception is accepted.
No payment handoff is available.
- No approved legal recipient, payment processor, bank, accounting platform, or custody route is published.
- No donation, sponsorship, affiliate, grant-intake, provider-intake, checkout, payment, refund, or tax-receipt surface is operating.
- No nonprofit, charitable, tax-deductible, public-benefit, investment, ownership, or treasury claim is established by these records.
- Funding records disclose reviewed institutional relationships and effects; raw donor, contract, banking, tax, negotiation, payroll, and personal source records remain private.